ES2167617T3 - Derivados de 1-bencenosulfonilpirrolidina como antagonistas del receptor de la bradiquinina. - Google Patents

Derivados de 1-bencenosulfonilpirrolidina como antagonistas del receptor de la bradiquinina.

Info

Publication number
ES2167617T3
ES2167617T3 ES96943182T ES96943182T ES2167617T3 ES 2167617 T3 ES2167617 T3 ES 2167617T3 ES 96943182 T ES96943182 T ES 96943182T ES 96943182 T ES96943182 T ES 96943182T ES 2167617 T3 ES2167617 T3 ES 2167617T3
Authority
ES
Spain
Prior art keywords
bencenosulfonilpirrolidina
bradiquinine
antagonists
receptor
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96943182T
Other languages
English (en)
Inventor
Pierre Dodey
Michel Bondoux
Patrick Houziaux
Martine Barth
Khan Ou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fournier Industrie et Sante SAS
Original Assignee
Fournier Industrie et Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Industrie et Sante SAS filed Critical Fournier Industrie et Sante SAS
Application granted granted Critical
Publication of ES2167617T3 publication Critical patent/ES2167617T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS ELEGIDOS ENTRE EL CONJUNTO FORMADO POR LOS COMPUESTOS DE FORMULA (I), EN LA CUAL X ES UN HALOGENO; R 1 REPRESENTA H O UN ALQUILO EN C 1 C 3 ; R 2 REPRESENTA H U OH; R 3 REPRESENTA (A), (B), (C) O (D); A REPRESENTA UN ENLACE SENCILLO O UN GRUPO - CO (CH 2 ) P - NH -; R 4 REPRESENTA H O C(=NR 5 )NHR 5 ; R 5 Y R 5 REPRESENTAN CADA UNO H O UN GRUPO ALQUILO EN C 1 - C 6 ; R 6 REPRESENTA H O UN GRUPO ALQUILO EN C 1 - C 3 ; M ES 0, 1 O 2; N ES 2, 3 O 4; P ES 1, 2 O 3; Y SUS SALES DE ADICION. SE REFIERE TAMBIEN A SU METODO DE PREPARACION Y SU UTILIZACION TERAPEUTICA.
ES96943182T 1995-12-29 1996-12-23 Derivados de 1-bencenosulfonilpirrolidina como antagonistas del receptor de la bradiquinina. Expired - Lifetime ES2167617T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515706A FR2743073B1 (fr) 1995-12-29 1995-12-29 Nouveaux composes de 1-benzenesulfonylpyrrolidine, procede de preparation et utilisation en therapeutique

Publications (1)

Publication Number Publication Date
ES2167617T3 true ES2167617T3 (es) 2002-05-16

Family

ID=9486120

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96943182T Expired - Lifetime ES2167617T3 (es) 1995-12-29 1996-12-23 Derivados de 1-bencenosulfonilpirrolidina como antagonistas del receptor de la bradiquinina.

Country Status (11)

Country Link
US (1) US6211181B1 (es)
EP (1) EP0874841B1 (es)
JP (1) JP2000502693A (es)
AT (1) ATE206418T1 (es)
AU (1) AU1198897A (es)
DE (1) DE69615707T2 (es)
DK (1) DK0874841T3 (es)
ES (1) ES2167617T3 (es)
FR (1) FR2743073B1 (es)
PT (1) PT874841E (es)
WO (1) WO1997024349A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
IL128666A (en) * 1996-08-28 2005-09-25 Procter & Gamble Substituted cyclic amine metalloprotease inhibitors
US6872742B2 (en) 1996-08-28 2005-03-29 The Procter & Gamble Company Substituted cyclic amine metalloprotease inhibitors
KR100352316B1 (ko) 1997-07-31 2002-09-12 더 프록터 앤드 갬블 캄파니 메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체
FR2790260B1 (fr) * 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique
KR20010102486A (ko) 1999-03-03 2001-11-15 데이비드 엠 모이어 알케닐- 및 알키닐-함유 메탈로프로테아제 저해제
JP2003505384A (ja) 1999-07-15 2003-02-12 ファーマコピーア，インコーポレーティッド ブラジキニンｂ１受容体アンタゴニスト
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
FR2819254B1 (fr) * 2001-01-08 2003-04-18 Fournier Lab Sa Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
FR2840897B1 (fr) 2002-06-14 2004-09-10 Fournier Lab Sa Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
WO2004087700A1 (fr) 2003-03-25 2004-10-14 Laboratoires Fournier S.A. Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
AU2013226013B2 (en) * 2012-02-29 2016-08-11 Baruch S. Blumberg Institute Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation and Their Method of Use
WO2016170382A1 (en) 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3632329A1 (de) 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
US5288725A (en) * 1992-10-15 1994-02-22 Merck & Co., Inc. Pyrroloquinoline Bradykinin antagonist
AU686115B2 (en) 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds

Also Published As

Publication number Publication date
WO1997024349A1 (fr) 1997-07-10
DE69615707T2 (de) 2002-08-08
FR2743073A1 (fr) 1997-07-04
FR2743073B1 (fr) 1998-02-20
EP0874841A1 (fr) 1998-11-04
AU1198897A (en) 1997-07-28
PT874841E (pt) 2002-03-28
DK0874841T3 (da) 2002-01-28
ATE206418T1 (de) 2001-10-15
US6211181B1 (en) 2001-04-03
DE69615707D1 (de) 2001-11-08
EP0874841B1 (fr) 2001-10-04
JP2000502693A (ja) 2000-03-07

Similar Documents

Publication Publication Date Title
ES2167617T3 (es) Derivados de 1-bencenosulfonilpirrolidina como antagonistas del receptor de la bradiquinina.
BRPI0000596B8 (pt) composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
ES2161373T3 (es) Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas.
DE60234092D1 (de) Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
EP0269574A3 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
DE69524251T2 (de) Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
DK0807633T3 (da) Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner
EA200000336A1 (ru) Антагонисты рецептора витронектина
ATE299871T1 (de) Neue zyklische depsipeptid pf1022 derivate
ATE191908T1 (de) Neue verbindungen
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
EA200400641A1 (ru) Производные 4-фенил-1-пиперазинила, -пиперидинила и -тетрагидропиридила и содержащая их фармацевтическая композиция
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
TR199901761T2 (xx) IL-8 resept�r antagonistleri.
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
TR200002808T2 (tr) İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.